MTHFS Human

5,10-Methenyltetrahydrofolate Synthetase Human Recombinant
Cat. No.
BT26930
Source
Escherichia Coli.
Synonyms
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase), HsT19268, Methenyl-THF synthetase, FLJ30410, EC 6.3.3.2.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTeks products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

MTHFS produced in E.Coli is a single, non-glycosylated polypeptide chain containing 223 amino acids (1-203a.a.) and having a molecular mass of 25.4 kDa.
MTHFS is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Methylenetetrahydrofolate synthetase (MTHFS) is a cytosolic enzyme involved in the folate metabolic pathway. It utilizes magnesium as a cofactor to catalyze the ATP-dependent conversion of 5-formyltetrahydrofolate (5-MTHF) to 5,10-methenyltetrahydrofolate (MTHF). MTHF serves as a substrate for methylenetetrahydrofolate reductase (MTHFR) in the synthesis of 5-MTHF and as a coenzyme for thymidylate synthase (FAD) in thymidine biosynthesis.
Description
Recombinant MTHFS protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 223 amino acids (residues 1-203) with a molecular weight of 25.4 kDa. The protein is expressed with an N-terminal 20-amino acid His-tag and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The MTHFS protein solution (0.5 mg/mL) is supplied in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 5 mM DTT, and 30% glycerol.
Purity
Purity is determined to be greater than 95% by SDS-PAGE analysis.
Stability
For short-term storage (2-4 weeks), the product should be stored at 4°C. For extended storage, it is recommended to store the product frozen at -20°C. To ensure long-term stability, the addition of a carrier protein (0.1% HSA or BSA) is recommended. Repeated freeze-thaw cycles should be avoided.
Synonyms
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase), HsT19268, Methenyl-THF synthetase, FLJ30410, EC 6.3.3.2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAAAAVSSAK RSLRGELKQR LRAMSAEERL RQSRVLSQKV IAHSEYQKSK RISIFLSMQD EIETEEIIKD IFQRGKICFI PRYRFQSNHM DMVRIESPEE ISLLPKTSWN IPQPGEGDVR EEALSTGGLD LIFMPGLGFD KHGNRLGRGK GYYDAYLKRC LQHQEVKPYT LALAFKEQIC LQVPVNENDM KVDEVLYEDS STA

Product Science Overview

Introduction

5,10-Methenyltetrahydrofolate synthetase (MTHFS) is an enzyme that plays a crucial role in the folate-dependent one-carbon metabolic network. This network is essential for the synthesis of purines, thymidine, and amino acids, which are vital for the growth and proliferation of cells . The human recombinant form of this enzyme is used in various research and therapeutic applications.

Function and Mechanism

MTHFS catalyzes the ATP- and Mg²⁺-dependent conversion of 5-formyltetrahydrofolate (5-FTHF) to 5,10-methenyltetrahydrofolate (5,10-MTHF) . This reaction is physiologically irreversible and is a key step in the interconversion of reduced folates involved in one-carbon metabolism . The enzyme’s activity is crucial for maintaining the flow of carbon through the one-carbon metabolic network, which supplies essential components for cellular growth .

Structural Insights

The absence of the three-dimensional structure of human MTHFS has historically hampered the rational design and optimization of drug candidates targeting this enzyme . However, recent studies have reported the structures of native human MTHFS, a binary complex of MTHFS with ADP, MTHFS bound with the N5-iminium phosphate reaction intermediate, and an enzyme-product complex . These structural insights have provided a unique strategy for substrate recognition and regulation of enzyme activity .

Inhibition and Therapeutic Potential

Inhibition of MTHFS has been shown to arrest the growth of human MCF-7 breast cancer cells . This makes MTHFS a potential target for the development of anticancer therapeutics. The folate-dependent one-carbon metabolic network, in which MTHFS operates, is a prime target for anticancer drugs. For example, methotrexate, an antifolate used in cancer chemotherapy, inhibits dihydrofolate reductase, another key enzyme in this network .

Recombinant Production

The human recombinant form of MTHFS is produced using recombinant DNA technology. This involves inserting the gene encoding MTHFS into a suitable expression system, such as bacteria or yeast, to produce the enzyme in large quantities. The recombinant enzyme is then purified for use in research and therapeutic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.